NYSE: ARDTArdent Health Partners Inc Stock
$12.51+0.21 (+1.71%)
Updated Apr 17, 2025
ARDT Price
$12.51
Fair Value Price
N/A
Market Cap
$1.79B
52 Week Low
$11.60
52 Week High
$20.72
P/E
7.87x
P/B
1.58x
P/S
0.38x
PEG
0.7x
Dividend Yield
N/A
Revenue
$5.97B
Earnings
$210.34M
Gross Margin
17.6%
Operating Margin
5.69%
Profit Margin
3.5%
Debt to Equity
3.04
Operating Cash Flow
$315M
Beta
0.52
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ARDT's potential to beat the market
AStrong Buy
- Stocks with a Zen Rating of Strong Buy (A) had an average return of +32.52% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
B
ARDT
Ranked#2 of 42
Ranked#2 of 42
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.82 | A | |
| $174.80 | A | |
| $23.65 | A |
Be the first to know about important ARDT news, forecast changes, insider trades & much more!
ARDT News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ARDT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ARDT ($12.51) is trading below its intrinsic value of $14.84, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ARDT is good value based on its earnings relative to its share price (7.87x), compared to the US market average (27.98x)
P/E vs Market Valuation
ARDT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more ARDT due diligence checks available for Premium users.
Valuation
ARDT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
7.87x
Industry
14.77x
Market
27.98x
ARDT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ARDT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ARDT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.58x
Industry
4.22x
ARDT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ARDT price to earnings growth (PEG)
For valuing profitable companies with growth potential
ARDT is good value based... subscribe to Premium to read more.
PEG Value Valuation
ARDT's financial health
Profit margin
Revenue
$1.6B
Net Income
$114.2M
Profit Margin
7.1%
ARDT's Earnings (EBIT) of $339.27M... subscribe to Premium to read more.
Interest Coverage Financials
ARDT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.0B
Liabilities
$3.4B
Debt to equity
3.04
ARDT's short-term assets ($1.83B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ARDT's long-term liabilities ($2.49B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ARDT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$119.6M
Investing
-$105.4M
Financing
-$20.5M
ARDT's operating cash flow ($315.03M)... subscribe to Premium to read more.
Debt Coverage Financials
ARDT vs Medical Care Facility Stocks
Ardent Health Partners Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.